DUBLIN--(BUSINESS WIRE)--The "Antacids Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global antacids market was valued at about $4.62 billion in 2018 and is expected to decline to $4.55 billion at a CAGR of -0.4% through 2022.
Antacids Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global antacids market.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
The antacids market consists of sales of antacids which are used to neutralize stomach acid, and treat acid reflux, heartburn and indigestion. It includes drug class such as proton pump inhibitors, H2 antagonist, surgical simulators and acid neutralizers in the form of either tablet, liquid or powder. Examples of antacids include Alka Seltzer, Maalox, Mylanta, Rolaids, Tums and Pepto-Bismol.
North America was the largest region in the antacids market in 2018. Asia Pacific and Latin America respectively.
Poor lifestyle choices resulting in higher prevalence of acidity is an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep and irregular dietary habits, which result in an increase in acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffers from gastroesophageal reflux disease. This drives the demand for antacids.
The side effects related to antacids is a major restraint for the antacids market. Some of the common side effects of antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may also cause side effects such as constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. In addition, antacids when consumed with other acidic drugs might lead to absorption of both the drugs resulting in reduced efficiency of both the drugs.
Mouth-melting antacid is an emerging trend in the antacid market. Antacids were available in tablet, liquid and powder form until now, however, researchers have now come up with mouth-melting antacids which are made up of micro mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth melting technology.
The manufacturers of antacids in the USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by the FDA. According to these regulations, an over-the-counter (OTC) antacid product in a form suitable for oral administration is recognized safe and effective only if it meets the conditions related to active ingredients established by the regulatory body.
In March 2018, GlaxoSmithKline (GSK) acquired Novartis for $13 billion. This acquisition would help GSK's shareholder to seize the full worth of Novartis' consumer healthcare business. Also, it would help GSK expand its pharmaceutical portfolio. Novartis is a pharmaceutical firm manufacturing innovative drugs. It was founded in 1996 and is headquartered in Basel, Switzerland.
Key Topics Covered:
1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Size And Growth
3.1. Global Antacids Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Antacids Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Antacids Market Segmentation
4.1. Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
4.2. Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Others
4.3. Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Tablet
- Liquid
- Powder
- Others
5. Antacids Market Regional And Country Analysis
5.1. Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Companies Mentioned
- GlaxoSmithKline plc
- Pfizer Inc
- Bayer AG
- Dr. Reddy's Laboratories Ltd
- AstraZeneca PLC
- Boehringer Ingelheim GmbH
- Sun Pharmaceuticals Industries Ltd
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
-
WellSpring Ph
For more information about this report visit https://www.researchandmarkets.com/r/nadm5v
